LCG
GMED icon

Lisanti Capital Growth’s Globus Medical GMED Stock Holding History

Lisanti Capital Growth’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,910
Closed -$1.31M – 122
2025
Q1 		$1.31M Sell
17,910
-430
-2% -$35.5K 0.39% 88
2024
Q4 		$1.52M Sell
18,340
-6,575
-26% -$519K 0.36% 90
2024
Q3 		$1.78M Buy
24,915
+10,120
+68% +$714K 0.45% 87
2024
Q2 		$1.01M Buy
+14,795
New +$884K 0.24% 101
2023
Q1 		– Sell
-128,240
Closed -$9.52M – 126
2022
Q4 		$9.52M Buy
+128,240
New +$8.73M 1.3% 24
2018
Q3 		– Sell
-41,215
Closed -$2.08M – 138
2018
Q2 		$2.08M Buy
41,215
+850
+2% +$44.3K 0.8% 56
2018
Q1 		$2.01M Buy
+40,365
New +$1.9M 0.97% 43
2014
Q3 		– Sell
-127,120
Closed -$3.04M – 98
2014
Q2 		$3.04M Buy
127,120
+12,245
+11% +$295K 1.36% 29
2014
Q1 		$3.06M Buy
+114,875
New +$2.73M 1.32% 30

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Lisanti Capital Growth's GMED Position: Q2 2025 in Review

Lisanti Capital Growth sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 17,910 shares — an estimated $1.31M sold.

Lisanti Capital Growth first reported a position in GMED in Q1 2014 and held it in 9 quarters. The position peaked at $9.52M in Q4 2022. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Lisanti Capital Growth reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • Lisanti Capital Growth sold 17,910 Globus Medical shares in Q2 2025, an estimated $1.31M.
  • Lisanti Capital Growth first reported a position in Globus Medical in Q1 2014 and held it in 9 quarters.
  • Lisanti Capital Growth's Globus Medical position peaked at $9.52M in Q4 2022.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Lisanti Capital Growth's 13F filing for Q2 2025, filed 7 Aug 2025.